Ravi

[Ken Milne MD @TheSGEM]

Save the Date for the Debate:
Thrombolysis in Stroke

https://t.co/OGNfhDdnnL

@TheStrokeAssoc @strokefm @UofTNeurology @ACEPNation @CAEP_Docs @RCEMLearning

[Neurocritical Care @NeurocritCareJ]

Letters to the Editor

Ravi Garg: When Precision Meets Bias: Questioning the Validity of Pooled Estimates in Intensive Blood Pressure Lowering for Intracerebral Hemorrhage Meta-Analyses

Link: https://t.co/QGbcOUnoOQ

@neurocritical #neurocritcare

[Ravi @ravigarg415]

Extended thrombolysis in acute ischemic stroke: A Bayesian meta-analysis
https://t.co/KHySVlNakY

[Ravi @ravigarg415]

What OPTIMISTmain Teaches About Margins, Imputation, and Interpretation: https://t.co/HSHARGjAuy

[Neurocritical Care @NeurocritCareJ]

Garg et al: Assessing the Clinical Relevance of Blood Pressure Measures in Spontaneous Intracerebral Hemorrhage: A Post Hoc Analysis of ATACH-2

Link: https://t.co/JJV6cDioBX

@neurocritical #neurocritcare

[Ravi @ravigarg415]

Assessing the Clinical Relevance of Blood Pressure Measures in Spontaneous Intracerebral Hemorrhage: A Post Hoc Analysis of ATACH-2 (https://t.co/gOdmS8NI9C)

[Neurocritical Care @NeurocritCareJ]

Letters to the editor:

Garg: Does Celecoxib Actually Reduce Mortality in Patients with Spontaneous Intracerebral Hemorrhage?

Link: https://t.co/FChx0gdrNX

https://t.co/E5BgZxUeEB

@neurocritical #neurocritcare

[Ravi @ravigarg415]

Implausibly early or late separation of the KM curve might be suggestive of residual confounding: https://t.co/3poZqfYCzR @VPrasadMDMPH

[JAMA Internal Medicine @JAMAInternalMed]

Most viewed in the last 7 days from @JAMAInternalMed:

Study examines the use of piperacillin-tazobactam compared with cefepime in 90-day mortality in patients treated empirically for sepsis.

https://t.co/mRzEAzAjkr

[Ravi @ravigarg415]

PubPeer post on https://t.co/TkygLr1rcQ including composite endpoint criteria from @vmontori
https://t.co/VlJj41ycVd

[Megan Rech, PharmD, MS @MeganARech]

Want to incorporate viscoelastic testing 🩸 into your practice but not sure where to start? Check out our primer on VET in critically ill populations here 👇

https://t.co/VHori3NWiV

⁦@CBthePHARMD⁩ ⁦@GilbertPharmD⁩ ⁦@ravigarg415⁩ ⁦@nei_scott⁩ #TwitteRx

[Purvi P. Patel MD, FACS @pppatelmd]

Wrapping up a high yield Neurocritical Care Review. Thank you @docmartin22 for coordinating and good luck to everyone taking the test! Just remember to think like a neurologist when doing those trauma questions. #AAST2022 #NeuroCriticalCare

[John Mandrola, MD @drjohnm]

Linked below is a provocative review of the original NINDS trial for thrombolysis in acute stroke

What if randomization errors underlie one of the most "positive" trials?

My 2018 opinion concluded too strongly, but there is still massive uncertainty https://t.co/tsITyjqLvw

[BMC @BioMedCentral]

A paper published in #BMCMedResMethodol found a high risk of selection bias in the NINDS rt-PA Stroke Study and recommends that treatment decisions based on the NINDS rt-PA Stroke Study should be done cautiously. https://t.co/3NkSdsR49B

[Ken Milne MD @TheSGEM]

@First10EM @MicieliA_MD @ICEM2022 @CCREM2 @CADTH_ACMTS @lowninstitute @ChooseWiselyCA @RightCareNow @emlitofnote @EverydayMed @cochranecollab @bmj_latest Published today by @ravigarg415 in the Dept of Neurology, Division of Neurocritical Care, Loyola University Chicago https://t.co/vLtdAxA00W

[Ravi @ravigarg415]

@Jorge_Ortiz_G ⓘ This claim about t-PA is disputed by multiple sources.

[Ken Milne MD @TheSGEM]

I would welcome feedback from #MedTwitter and those with more expertise than me on the re-analysis of ECASS-3
@ADAlthousePhD @janetmartinwho

https://t.co/FkUoMmyhhr

[Ravi @ravigarg415]

Thanks for publishing our paper! @JSCVD2 @MeganARech

[JSCVD @JSCVD2]

Should stroke mimics be included in #stroke research? Check our this paper.

https://t.co/LtwJzHotrg

[Ravi @ravigarg415]

@hanikuttab @UChicagoEM Nice job Hani!

[Ravi @ravigarg415]

@arielhelwani @marc_raimondi What kind of cognitive or neurological testing do MMA fighters undergo to be cleared for a fight? Matt Hughes, BJ Penn, Mirko Cro Crop, and many more fighters have been in the new with stories of behavior that is very suspicious for an underlying neurodegenerative disorder.

[Megan Rech, PharmD, MS @MeganARech]

Is #strokemimic artificially inflating favorable outcomes in stroke patients treated with alteplase? Our new research ⁦@LoyolaHealth⁩ suggests it might https://t.co/DSsp6sUcH1